Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1242.00
-3.50 (-0.28%)
< Home < Back

Dr. Reddys Laboratories informs about company updates

Date: 17-02-2020

Further to the intimation dated August 20, 2019 with regard to the audit of its Formulations Manufacturing Plant ('Vizag SEZ Plant 1 - FTO 7') at Duvvada, Visakhapatnam, Dr. Reddys Laboratories has informed that the company has been notified by the US FDA, that the inspection classification of the above-referred facility is determined as Voluntary Action Initiated (VAI).

The above information is a part of company’s filings submitted to BSE.